Year To Quarter End Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7298873

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Year to quarter end statement of income
Statement of income
Net sales
55,139,000,000 JPY
54,937,000,000 JPY
Cost of sales
31,575,000,000 JPY
31,101,000,000 JPY
Gross profit (loss)
23,564,000,000 JPY
23,836,000,000 JPY
Selling, general and administrative expenses
22,015,000,000 JPY
22,500,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
1,549,000,000 JPY
1,335,000,000 JPY
Non-operating income
Interest income
0 JPY
17,000,000 JPY
Dividend income
248,000,000 JPY
251,000,000 JPY
Non-operating income
571,000,000 JPY
313,000,000 JPY
Non-operating expenses
Interest expenses
54,000,000 JPY
33,000,000 JPY
Non-operating expenses
69,000,000 JPY
70,000,000 JPY
Ordinary profit (loss)
2,050,000,000 JPY
1,578,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
0 JPY
0 JPY
Extraordinary income
0 JPY
969,000,000 JPY
Extraordinary losses
Extraordinary losses
181,000,000 JPY
8,000,000 JPY
Profit (loss) before income taxes
1,869,000,000 JPY
2,540,000,000 JPY
Income taxes
613,000,000 JPY
649,000,000 JPY
Profit (loss)
1,255,000,000 JPY
1,890,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.